Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06513208 · ClinicalTrials.gov registry record · Phase 4
Ketorolac Effects on Post-operative Pain and Lumbar Fusion
A Phase 4 study of Lumbar Spinal Fusion, sponsored by University of Maryland St. Joseph Medical Center.
- Recruiting
- Registry status
- Phase 4
- Development phase
- 140
- Enrollment target
- 1
- Study location
NCT06513208 is a Phase 4 study of Lumbar Spinal Fusion that is actively recruiting participants, run by University of Maryland St. Joseph Medical Center. The registered enrollment target is 140 participants. The trial reports 1 study location across 1 state.
The verdict
NCT06513208, a Phase 4 study of Lumbar Spinal Fusion, is actively recruiting participants, sponsored by University of Maryland St. Joseph Medical Center.
- RECRUITING
- Registry status
- Phase 4
- Development phase
- 140 participants
- Enrollment target
- 1
- Study location
Study Summary
A double blind prospective randomized trial of IV ketorolac vs. placebo in management of patients undergoing lumbar one or two level spinal fusions.
Conditions Studied
Interventions
- DRUG Placebo
- DRUG Ketorolac Tromethamine
Study Locations (1)
Maryland
- University of Maryland St. Joseph Medical Center - Towson
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 140 participants |
| Start Date | 2026-01 |
| Est. Completion | 2027-06 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06513208
The ClinicalTrials.gov registry entry for NCT06513208 describes a study currently listed as recruiting, categorized as Phase 4. The registered enrollment target is 140 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Maryland St. Joseph Medical Center, which has 2 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Lumbar Spinal Fusion appearing as the primary indexed condition, and to 2 interventions - of which Placebo is the first listed.
NCT06513208 reports 1 study location spanning 1 distinct geographic area - top geographies include Maryland.
Frequently Asked Questions
What is clinical trial NCT06513208 about?
NCT06513208 is a clinical study titled "Ketorolac Effects on Post-operative Pain and Lumbar Fusion". A double blind prospective randomized trial of IV ketorolac vs. placebo in management of patients undergoing lumbar one or two level spinal fusions.
What is the current status of trial NCT06513208?
This trial is currently recruiting. It is a Phase 4 study. The enrollment target is 140 participants. The study started on 2026-01. Estimated completion is 2027-06.
What conditions does trial NCT06513208 study?
This clinical trial studies the following conditions: Lumbar Spinal Fusion.
What interventions are being tested in trial NCT06513208?
The interventions under investigation include: Placebo (DRUG), Ketorolac Tromethamine (DRUG).
Who is sponsoring clinical trial NCT06513208?
This trial is sponsored by University of Maryland St. Joseph Medical Center, which has 2 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06513208 being conducted?
This trial has 1 study location across Maryland. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.